Nanotechnology in coronary heart disease
Acta Biomaterialia · 2023-11 · 171 · 37-67
DOI: 10.1016/j.actbio.2023.09.011 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Biomaterialia, 2023-11. Verfasst von Junsong Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Academician Workstation, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, China; Department of Cardiology, Affiliated …. Hauptthemen laut MEDLINE: Coronary Disease, Nanostructures. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 315 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chinese Academy of Sciences, Ministry of Science and Technology of the People's Republic of China.
Abstract (Originalsprache)
Coronary heart disease (CHD) is one of the major causes of death and disability worldwide, especially in low- and middle-income countries and among older populations. Conventional diagnostic and therapeutic approaches have limitations such as low sensitivity, high cost and side effects. Nanotechnology offers promising alternative strategies for the diagnosis and treatment of CHD by exploiting the unique properties of nanomaterials. In this review, we use bibliometric analysis to identify research hotspots in the application of nanotechnology in CHD and provide a comprehensive overview of the current state of the art. Nanomaterials with enhanced imaging and biosensing capabilities can improve the early detection of CHD through advanced contrast agents and high-resolution imaging techniques. Moreover, nanomaterials can facilitate targeted drug delivery, tissue engineering and modulation of inflammation and oxidative stress, thus addressing multiple aspects of CHD pathophysiology. We discuss the application of nanotechnology in CHD diagnosis (imaging and sensors) and treatment (regulation of macrophages, cardiac repair, anti-oxidative stress), and provide insights into future research directions and clinical translation. This review serves as a valuable resource for researchers and clinicians seeking to harness the potential of nanotechnology in the management of CHD. STATEMENT OF SIGNIFICANCE: Coronary heart disease (CHD) is the one of leading cause of death and disability worldwide. Nanotechnology offers new strategies for diagnosing and treating CHD by exploiting the unique properties of nanomaterials. This review uses bibliometric analysis to uncover research trends in the use of nanotechnology for CHD. We discuss the potential of nanomaterials for early CHD detection through advanced imaging and biosensing, targeted drug delivery, tissue engineering, and modulation of inflammation and oxidative stress. We also offer insights into future research directions and potential clinical applications. This work aims to guide researchers and clinicians in leveraging nanotechnology to improve CHD patient outcomes and quality of life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Academician Workstation, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, China; Department of Cardiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, C…
- CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nano-safety, Institute of High Energy Physics, Beijing 100049, China; CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technolo…
- Academician Workstation, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, China; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nano-safety, Institute of High Energy Physic…
Förderung
- National Natural Science Foundation of China
- Chinese Academy of Sciences
- Ministry of Science and Technology of the People's Republic of China
- Natural Science Foundation of Beijing Municipality
- National Key Research and Development Program of China
Zitieren
APA
Guo, J., Wang, H., Li, Y., Zhu, S., Hu, H., & Gu, Z. (2023). Nanotechnology in coronary heart disease. Acta Biomaterialia, 171, 37-67. https://doi.org/10.1016/j.actbio.2023.09.011
Vancouver
Guo J, Wang H, Li Y, Zhu S, Hu H, Gu Z. Nanotechnology in coronary heart disease. Acta Biomaterialia. 2023;171:37-67. doi:10.1016/j.actbio.2023.09.011
BibTeX
@article{Guo2023,
author = {Guo, Junsong and Wang, Hao and Li, Ying and Zhu, Shuang and Hu, Houxiang and Gu, Zhanjun},
title = {Nanotechnology in coronary heart disease},
journal = {Acta Biomaterialia},
year = {2023},
volume = {171},
pages = {37--67},
doi = {10.1016/j.actbio.2023.09.011}
}
EUVIMED